Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-117-2 | CAS number: 10039-33-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 (oral) = 3793 mg/kg (male/female rat)
LD50 (dermal) >2000 mg/kg bw (male/female rat)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 793 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute Oral Toxicity
The acute toxicity of the substance was assessed after the single oral administration of the substance at 4 g/kg bw in white mice. The dose was selected based on a preliminary study (48 -hr observation period) where an LD50 = 2700 mg/kg bw was determined. After 24 hours all animals were sacrificed and histopathology was performed in some tissues. No mortality was observed during the study. Some clinical signs, macroscopical and microscopical findings were observed in the liver, spleen, lungs, stomach and colon. However, since all animals were sacrificed 24 hours after intubation, reversibility of these signs was not able to be evaluated.
The (non) acute toxicity of the substance is supported by available experimental data on Similar Substance 02. Its acute oral toxicity was evaluated in the key study according to the standardised guideline OECD 401. Albino rats were administered a single oral dose of the test material by gavage at dose levels of 1000, 2500 and 5000 mg/kg bw. Five animals per sex were dosed at each concentration and the animals observed for 14 days. Four male and four female animals died within 5 days at the 5000 mg/kg bodyweight dose level. No further mortality was seen. Clinical signs included sedation, dyspnoea, exophthalmus, ruffled fur and exhibiting a curved body position. All survivors had recovered by the end of the observation period and no gross abnormalities were observed at necropsy. LD50 = 3793 mg/kg bw.
For chemical safety assesseent the LD50 = 3793 mg/kg bw is used since it is obtained by a study performed according to the OECD guideline 401 and under GLP conditions. In addition, an adequate observation period which permits the better evaluation of the presence/absence of clinical signs and mortality. The LD50 of 2700 mg/kg bw is not used for CSA even if it is obtained by a study conducted on the substance, since the observation period was lower (only 48 hours) and no details on clinical signs and mortality are known.
Acute Inhalation Toxicity
In accordance with Column 2, point 8.5.2 of Annex VIII, testing by the inhalation route is appropriate if exposure of humans via inhalation is likely, taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size. Based upon the available vapour pressure of 1.58.10-013 Pa at 25 °C, exposure to the test material via inhalation is considered unlikely. Acute toxicity data via the oral route and via the dermal route (on Similar Substance 02) are instead provided.
Acute Dermal Toxicity
In the acute dermal toxicity study on Similar Substance 02, a LD50 > 2000 mg/kg bw was determined. Justification for Read Across is given in Section 13 of IUCLID. The acute dermal toxicity of the analogue substance was investigated in accordance with the standardised guidelines OECD 402 and EU Method B.3. During the study, a group of ten animals (five males and five females) was given a single 24 hour, semi-occluded dermal application of the test material to intact skin clipped free of hair at a dose level of 2000 mg/kg bw. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy. During the study there were no deaths and no signs of systemic toxicity were observed. One female showed bodyweight loss during the first week but expected gain in bodyweight during the second week and one female showed expected gain in bodyweight during the first week but bodyweight loss during the second week. Remaining animals showed expected gains in bodyweight over the study period. Signs of dermal irritation noted were very slight erythema, crust formation and desquamation. There were no signs of dermal irritation noted at the test site of one male. No abnormalities were noted at necropsy.
Justification for Read Across is given in Section 13 of IUCLID.
Justification for classification or non-classification
Fot the assessmenent of classification of the substance data on the substance but also data on analogue substances is used.
LD50 (oral) = 3793 mg/kg bw.
LD50 (dermal) > 2000 mg/kg bw.
The LD50 values determined via both dermal and oral route are higher than the threshold for classification. The substance is therefore not classified for acute toxicity according to the CLP Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.